EMD-23472

Single-particle
31.0 Å
EMD-23472
3D View Gallery
Deposition: 11/02/2021
Map released: 05/05/2021
Last modified: 26/05/2021
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-23472
Download
3D volume (map.gz) Experimental metadata (xml)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

SARS-CoV-2 spike complexed with Fab CV38-142 (2 Fabs bound)

EMD-23472

Single-particle
31.0 Å
EMD-23472
3D View Gallery
Deposition: 11/02/2021
Map released: 05/05/2021
Last modified: 26/05/2021
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: SARS-CoV-2 spike complexed with Fab CV38-142 (2 Fabs bound)

Deposition Authors: Bangaru S, Ward AB
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.
Liu H , Yuan M , Huang D, Bangaru S , Zhao F, Lee CD, Peng L , Barman S , Zhu X, Nemazee D, Burton DR, van Gils MJ , Sanders RW, Kornau HC, Reincke SM , Pruss H, Kreye J , Wu NC , Ward AB, Wilson IA
(2021) Cell Host Microbe , 29 , 806 - 818.e6
PUBMED: 33894127
DOI: doi:10.1016/j.chom.2021.04.005
ISSN: 1934-6069